- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Company Profile for Arqule Inc (ARQL)
ArQule Inc. develops cancer therapeutics based on its proprietary Activated Checkpoint Therapy platform. The Company's platform is designed to produce small molecule compounds that selectively kill cancer cells while leaving normal cells unharmed. ArQule's products are intended to be effective against multiple types of cancer.
Contact Information
Arqule Inc
19 Presidential Way
Woburn, MA 01801-5140
United States
Key Executives for Arqule Inc (ARQL)
| Paolo PucciChief Executive Officer | Peter S LawrencePresident/COO/Secy/Gen Cnsl |
| Brian SchwartzSenior VP/Chief Medical Ofcr | Thomas C K ChanSenior VP/Chf Scientific Ofcr |
| William B BoniVP:Investor Relations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page